Monday, October 23, 2023 1:56:48 PM
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”
Warren Buffett
Recent TCBP News
- TCBP Announces Launch of Compassionate Use Program for TCB008 • PR Newswire (US) • 05/15/2024 12:30:00 PM
- TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds • PR Newswire (US) • 05/06/2024 05:01:00 PM
- TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies • PR Newswire (US) • 05/06/2024 12:30:00 PM
- TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies • PR Newswire (US) • 04/04/2024 12:32:00 PM
- TCBP Increasing Treatment Capacity with Expanded Manufacturing Process • PR Newswire (US) • 04/02/2024 12:30:00 PM
- TCBP Adjourns General Meeting Until a Later Date • PR Newswire (US) • 03/19/2024 12:30:00 PM
- TCBP Announces Exercise of Series D Warrants For Cash • PR Newswire (US) • 03/18/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 11:30:38 AM
- Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show" • PR Newswire (US) • 03/01/2024 01:30:00 PM
- /C O R R E C T I O N -- TC BioPharm/ • PR Newswire (US) • 02/27/2024 10:15:00 PM
- TCBP Announces Shareholder Update Call on March 5th 2024 • PR Newswire (US) • 02/27/2024 01:30:00 PM
- TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial • PR Newswire (US) • 02/22/2024 02:32:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/20/2024 11:05:14 AM
- TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe • PR Newswire (US) • 02/15/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 07:48:40 PM
- TCBP Provides Shareholder Update and Highlights Upcoming Milestones • PR Newswire (US) • 02/14/2024 01:30:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/09/2024 08:26:49 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/29/2024 02:16:48 PM
- TC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show' • PR Newswire (US) • 01/29/2024 01:30:00 PM
- TC BioPharm to Present at the Sequire Investor Summit • PR Newswire (US) • 01/18/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:46:05 PM
- TC BioPharm Regains Compliance with Nasdaq Minimum Bid Price Requirement • PR Newswire (US) • 01/04/2024 01:30:00 PM
- TC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline Efficiencies • PR Newswire (US) • 01/03/2024 01:30:00 PM
- TC BioPharm Announces Closing of $3.5 Million Public Offering • PR Newswire (US) • 12/22/2023 01:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/21/2023 10:14:09 PM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM